Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

IMGO

Imago BioSciences (IMGO)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IMGO
DataOraFonteTitoloSimboloCompagnia
14/02/202314:27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGOImago BioSciences Inc
23/01/202313:26Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:IMGOImago BioSciences Inc
17/01/202312:07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:IMGOImago BioSciences Inc
12/01/202322:32Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IMGOImago BioSciences Inc
11/01/202322:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGOImago BioSciences Inc
11/01/202316:42Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:IMGOImago BioSciences Inc
11/01/202315:25Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:IMGOImago BioSciences Inc
11/01/202315:19Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:IMGOImago BioSciences Inc
11/01/202315:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGOImago BioSciences Inc
11/01/202314:58Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:IMGOImago BioSciences Inc
11/01/202314:51Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:IMGOImago BioSciences Inc
20/12/202222:05GlobeNewswire Inc.Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 2 Study of Bomedemstat in Combination with Ruxolitinib in MyelofibrosisNASDAQ:IMGOImago BioSciences Inc
12/12/202217:30GlobeNewswire Inc.Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at ASH 2022NASDAQ:IMGOImago BioSciences Inc
12/12/202216:00GlobeNewswire Inc.Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Advanced Myelofibrosis at ASH 2022NASDAQ:IMGOImago BioSciences Inc
12/12/202214:22Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:IMGOImago BioSciences Inc
12/12/202212:54Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:IMGOImago BioSciences Inc
12/12/202212:45Business WireMerck Begins Tender Offer to Acquire Imago BioSciences, Inc.NASDAQ:IMGOImago BioSciences Inc
30/11/202222:05GlobeNewswire Inc.Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 1 Study of Bomedemstat in Combination with Venetoclax in Relapsed/Refractory Acute Myeloid LeukemiaNASDAQ:IMGOImago BioSciences Inc
22/11/202212:30TipRanksAnalysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN) and Imago BioSciences (IMGO)NASDAQ:IMGOImago BioSciences Inc
21/11/202223:24Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:IMGOImago BioSciences Inc
21/11/202220:35Dow Jones NewsTrending: Merck to Acquire Imago BioSciences for $1.35 BillionNASDAQ:IMGOImago BioSciences Inc
21/11/202216:32Dow Jones NewsImago BioSciences Shares Take Flight on Takeover by MerckNASDAQ:IMGOImago BioSciences Inc
21/11/202215:16Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:IMGOImago BioSciences Inc
21/11/202213:47TipRanksMerck Snaps Up Imago for $1.35 BillionNASDAQ:IMGOImago BioSciences Inc
21/11/202213:29Dow Jones NewsMerck to Buy Imago for $36 A Share, More Than Double Friday's CloseNASDAQ:IMGOImago BioSciences Inc
21/11/202212:45Business WireMerck to Acquire Imago BioSciences, Inc.NASDAQ:IMGOImago BioSciences Inc
11/11/202212:26TipRanksImago BioSciences (IMGO) Receives a Buy from H.C. WainwrightNASDAQ:IMGOImago BioSciences Inc
09/11/202222:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMGOImago BioSciences Inc
09/11/202222:05GlobeNewswire Inc.Imago BioSciences Reports Third Quarter 2022 Financial Results and Provides Recent Business UpdatesNASDAQ:IMGOImago BioSciences Inc
07/11/202222:05GlobeNewswire Inc.Imago BioSciences to Participate in Upcoming Investor ConferencesNASDAQ:IMGOImago BioSciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IMGO
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network